^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Lung Non-Squamous Non-Small Cell Cancer |
| Regimen: | GT (gemcitabine + paclitaxel) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
09/15/2020
Excerpt:
For patients with metastatic nonsquamous NSCLC and PS 0 and 1 who have contradictions to immunotherapy, the panel decided that the following chemotherapy regimens are "useful in certain circumstances" including…gemcitabine with either docetaxel or vinorelbine.
